Fetal Retinoid SyndromeSymptoms, Doctors, Treatments, Advances & More
Fetal Retinoid Syndrome Overview
Learn About Fetal Retinoid Syndrome
- Fetal retinoid syndrome
- Accutane fetal effects of
- Accutane-exposed pregnancies
- Acutane embryopathy
- Isotretinoin (RoAccutane) embryopathy
- Isotretinoin embryopathy
- Isotretinoin fetal effects of
- Isotretinoin teratogen syndrome
Abraham Fainsod practices practicing medicine in Jerusalem, Israel. Mr. Fainsod is rated as an Elite expert by MediFind in the treatment of Fetal Retinoid Syndrome. He is also highly rated in 2 other conditions, according to our data. His clinical expertise encompasses Fetal Retinoid Syndrome, Fetal Alcohol Syndrome (FAS), Campomelic Dysplasia, and Campomelia Cumming Type.
Office
Christopher Bunick is a Dermatologist practicing medicine in Middlebury, Connecticut. Dr. Bunick is rated as a Distinguished provider by MediFind in the treatment of Fetal Retinoid Syndrome. He is also highly rated in 16 other conditions, according to our data. His clinical expertise encompasses Lamellar Ichthyosis, Nonbullous Congenital Ichthyosiform Erythroderma, Acne, and Atopic Dermatitis.
Lucille Packard Children's Hospital 030962
Joyce Teng is a Pediatrics provider practicing medicine in Palo Alto, California. Dr. Teng is rated as a Distinguished provider by MediFind in the treatment of Fetal Retinoid Syndrome. She is also highly rated in 136 other conditions, according to our data. Her clinical expertise encompasses Dowling-Meara Epidermolysis Bullosa Simplex, Dominant Dystrophic Epidermolysis Bullosa, Nevoid Basal Cell Carcinoma Syndrome, Fetal Retinoid Syndrome, and Liver Embolization.
Summary: The novel coronavirus (SARS-CoV-2) infection (COVID-19) has caused a worldwide pandemic. There is still much that is unknown regarding the virus, especially its effects on pregnancy, the fetus, and the neonate. This study seeks to evaluate adverse pregnancy and neonatal outcomes related to COVID-19 infection. The FDA has authorized emergency use authorization for the SARS-CoV-2 messenger ribonucle...
Summary: Johns Hopkins clinical research office quality assurance group will monitor and audit this study at Johns Hopkins. The Sub Investigator at each site will be responsible for internal monitoring at their site.
Published Date: May 02, 2022
Published By: Genetic and Rare Diseases Informnation Center